rdf:type |
|
lifeskim:mentions |
umls-concept:C0011860,
umls-concept:C0030705,
umls-concept:C0035647,
umls-concept:C0038766,
umls-concept:C0123658,
umls-concept:C0175668,
umls-concept:C0205217,
umls-concept:C0205419,
umls-concept:C0231174,
umls-concept:C0332281,
umls-concept:C0332307
|
pubmed:issue |
6
|
pubmed:dateCreated |
2004-5-26
|
pubmed:abstractText |
The aim of this study was to investigate whether diabetic patients carrying the Arg(972) insulin receptor substrate-1 (IRS-1) variant are at increased risk for secondary failure to sulfonylurea.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0149-5992
|
pubmed:author |
pubmed-author:AndreozziFrancescoF,
pubmed-author:CardelliniMarinaM,
pubmed-author:FedericiMassimoM,
pubmed-author:FrontoniSimonaS,
pubmed-author:GnassoAgostinoA,
pubmed-author:IraceConcettaC,
pubmed-author:LauroDavideD,
pubmed-author:LauroRenatoR,
pubmed-author:MariniMaria AlelaideMA,
pubmed-author:PerticoneFrancescoF,
pubmed-author:SciacquaAngelaA,
pubmed-author:SestiGiorgioG
|
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1394-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15161794-Adult,
pubmed-meshheading:15161794-Aged,
pubmed-meshheading:15161794-Amino Acid Substitution,
pubmed-meshheading:15161794-Arginine,
pubmed-meshheading:15161794-Diabetes Mellitus, Type 2,
pubmed-meshheading:15161794-European Continental Ancestry Group,
pubmed-meshheading:15161794-Female,
pubmed-meshheading:15161794-Genetic Markers,
pubmed-meshheading:15161794-Genetic Variation,
pubmed-meshheading:15161794-Humans,
pubmed-meshheading:15161794-Hypoglycemic Agents,
pubmed-meshheading:15161794-Insulin Receptor Substrate Proteins,
pubmed-meshheading:15161794-Male,
pubmed-meshheading:15161794-Middle Aged,
pubmed-meshheading:15161794-Phosphoproteins,
pubmed-meshheading:15161794-Sulfonylurea Compounds,
pubmed-meshheading:15161794-Treatment Failure
|
pubmed:year |
2004
|
pubmed:articleTitle |
The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.
|
pubmed:affiliation |
Dipartimento di Medicina Sperimentale e Clinica, Università Magna Graecia di Catanzaro-Via Tommaso Campanella, 115 88100 Catanzaro, Italy. sesti@unicz.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|